InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,244.00
(
1.57%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.00%
)
Bitcoin
63,018.45
(
-1.13%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 82
Posts 12422
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Thursday, 10/23/2014 12:58:21 PM

Thursday, October 23, 2014 12:58:21 PM

Post# of 80490
I think that post on '113 makes it abundantly clear. There is immediate value in Ariad, and if they continue on this path, they will run out of money. '113 has to be best in class, and with the other six new drugs, for ALK+, it will be difficult. Molecule nEW is the only hope for a sale in the $12's.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up